Archive

Author: Marco Propersi

Short Course Antibiotics for Peds CAP: A Systematic Review and Meta-Analysis

Background: There is a shifting paradigm with persuasive evidence favoring a shorter duration of antibiotics for outpatient management of community-acquired pneumonia (CAP) in children. The SAFER and CAP-IT trials found that short-course antibiotic therapy was not inferior to standard duration …

Read More
Infectious DiseasePediatrics

Traumatic Hemothorax: Pigtail vs Chest Tube

Background: Optimal management of pneumothorax and hemothorax with chest thoracostomy has been widely debated over the last decade.  We no longer question the utility of pigtail catheters for pneumothorax and now ask whether a catheter has to be placed at …

Read More
Thoracic and RespiratoryTrauma

REBEL Cast Book Club Episode 3 — An Astronaut’s Guide To Life on Earth

In this episode of the REBEL Cast Book Club, Swami, Marco, Steve, and Brandon discuss how the lessons learned from Col. Chris Hadfield’s “An Astronaut’s Guide to Life on Earth” might apply to emergency medicine.

Read More

The SCOUT–CAP Trial: 5d Abx vs. 10d Abx in Pediatric CAP

Background: The standard approach to treating pediatric community-acquired pneumonia (CAP) is a 10-day course of antibiotics. However, two high-quality randomized control trials challenged this standard within the last 12 months. The SAFER Trial [reviewed here] and CAP-IT Trial [reviewed here] found treatment for CAP in …

Read More
Infectious DiseasePediatricsThoracic and Respiratory

The ACTION Trial: DOACs in Hospitalized Patients with COVID-19

Background: Patients hospitalized with COVID-19 are at increased risk for both arterial and venous thromboembolic disease. Multiple recent trials have investigated the efficacy of therapeutic or standard prophylactic anticoagulation in preventing thrombotic complications among patients with COVID-19 in a variety …

Read More
CardiovascularInfectious DiseaseThoracic and Respiratory

Sponsored

0